MAPT and Alzheimer disease: In this regard, by longitudinally measuring the intensity of atrophy in AD susceptible brain regions against Aβ and tau deposition and assessing how this affects the way cognitive function changes, we can clarify the current findings with a more comprehensive understanding of cognitive reserve and brain maintenance.